This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: Gorane Santamaria: Innovator in Breast Cancer Risk Assessment
Introduction
Gorane Santamaria is an accomplished inventor based in Bowen Hills, Australia. She has made significant contributions to the field of medical technology, particularly in the assessment of breast cancer risk. Her innovative approach combines advanced spectroscopy techniques with clinical applications, aiming to improve early detection and risk evaluation for patients.
Latest Patents
Gorane Santamaria holds a patent for a groundbreaking invention titled "Method and system for acquiring spectral data for use in assessing risk of breast cancer." This patent describes a method that utilizes a magnetic resonance spectroscopy device to measure spectral signals at specific frequencies within breast tissue. By comparing these measurements to reference levels from healthy subjects, the system can determine whether an individual is at an elevated risk of developing breast cancer.
Career Highlights
Throughout her career, Gorane has focused on integrating technology with healthcare solutions. Her work has been pivotal in advancing methodologies that enhance the accuracy of breast cancer risk assessments. With a patent portfolio that includes 1 patent, she continues to push the boundaries of innovation in medical diagnostics.
Collaborations
Gorane has collaborated with notable professionals in her field, including Peter Malycha and Natali Naude. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of her work.
Conclusion
Gorane Santamaria's contributions to breast cancer risk assessment through her innovative patent demonstrate her commitment to improving healthcare outcomes. Her work exemplifies the intersection of technology and medicine, paving the way for future advancements in cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile